Cited by 80Retinal Development and DisordersVirus-based gene therapy researchRetinal Diseases and Treatments

Gene therapy for retinal disease

Open access
McClements, Michelle E., MacLaren, Robert E.·2013·Translational Research

Abstract

Gene therapy strategies for the treatment of inherited retinal diseases have made major advances in recent years. This review focuses on adeno-associated viral (AAV) vector approaches to treat retinal degeneration and, thus, prevent or delay the onset of blindness. Data from human clinical trials of gene therapy for retinal disease show encouraging signs of safety and efficacy from AAV vectors. Recent progress in enhancing cell-specific targeting and transduction efficiency of the various retinal layers plus the use of AAV-delivered growth factors to augment the therapeutic effect and limit cell death suggest even greater success in future human trials is possible.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trsl.2012.12.007

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

3 of the 176 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
McClements, M. E., & MacLaren, R. E.
Affiliations
  • University of Oxford (GB)
  • National Institute for Health and Care Research (GB)
Corresponding author
MacLaren, Robert E.
Venue
Translational Research
Publisher
Elsevier BV
Published
2013-04
Volume
161
Issue
4
Pages
241-254
ISSN
  • 1878-1810 (ISSN-L)
  • 1931-5244
OpenAlex
W1974565469
Cited by
80
References
176
Citations by year
2026: 6 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 7 · 2019: 8 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 11 · 2014: 14 · 2013: 5 · 2012: 1
FWCI
1.16
Type
journal article
Language
en
Open access
Locations
  • Translational research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
Medical Research Council (MR/K007629/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
gene therapy, retinal degeneration, inherited retinal disease, adeno-associated virus vectors, blindness prevention, cell-specific targeting, transduction efficiency, growth factor delivery, clinical trials, retinal layers
MeSH terms
Animals, Clinical Trials as Topic, Genetic Vectors, Humans, Promoter Regions, Genetic, Retinal Diseases, Genetic Therapy, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review